Moffitt Cancer Center;Acetylon Pharmaceuticals, Inc.
发明人:
申请号:
EP14853051.2
公开号:
EP3054954A4
申请日:
2014.10.07
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The invention relates to HDAC inhibitors, or combinations comprising an HDAC inhibitor and a BTK inhibitor for the treatment of non-hodgkin's lymphoma in a subject in need thereof. Also provided herein are methods for treating non-hodgkin's lymphoma in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an HDAC inhibitor, or a combination comprising an HDAC inhibitor and a BTK inhibitor.